Infectious Diseases (except HIV/AIDS)
Showing page 182 of 716 pages of list content
-
Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
This article's authors -
Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records
This article's authors -
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
This article's authors -
Mathematical modelling of COVID-19 transmission dynamics with vaccination: A case study in Ethiopia
This article's authors -
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial
This article's authors -
Home Care Follow up determine the point of inversion of IL-6 levels in relation to C-Reactive Protein as the cytokine storm marker in COVID-19
This article's authors -
Determinants of passive antibody efficacy in SARS-CoV-2 infection
This article's authors -
Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors
This article's authors -
Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial
This article's authors -
Where the truth really lies: Listening to voices from African American communities in the Southern States about COVID-19 vaccine information and communication
This article's authors